First cell-culture flu vaccine approved

Share this article:
First cell-culture flu vaccine approved
First cell-culture flu vaccine approved

HealthDay News -- The FDA has approved Flucelvax (Novartis), the first seasonal flu vaccine using a manufacturing method called cell culture technology, the agency said.

Other flu vaccines are produced inside eggs, but that process takes longer than the newer method and could be harmful to people with egg allergies. In cell culture technology, virus strains are grown inside mammalian animal cells, the FDA explained in a press release.

This technology has been used for decades to produce other vaccines and since it is quicker, it can be used more efficiently to develop flu vaccines rapidly in the event of a pandemic.

The approval comes after a placebo-controlled clinical trial conducted during the 2007-2008 flu season in the U.S., Finland and Poland, showed the vaccine had an efficacy of 83.8% in preventing infection -- similar to a conventional flu vaccine -- among adults 18 to 49 years old.

A separate study in individuals 65 and older also demonstrated efficacy comparable with a conventional product. 

Common side effects include pain, redness, injection-site soreness, headache and fatigue -- reactions typically seen in people given egg-based flu vaccines, the FDA said.

The U.S. Centers for Disease Control and Prevention recommends the annual flu shot for anyone 6 months and older. Neither the FDA, nor Novartis indicated when Flucelvax will be commercially available.

More Information

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Urge all patients to get flu vaccine

Urge all patients to get flu vaccine

Flu-related complications last year caused more than 100 deaths in children and most of whom were not vaccinated.

Insulin pumps decrease mortality, cardiovascular disease risk

Insulin pumps decrease mortality, cardiovascular disease risk

Compared with multiple daily injections, patients who used continuous subcutaneous insulin infusion (CSII) had a lower likelihood of developing cardiovascular disease.

High-fat dairy products cut type 2 diabetes risk

High-fat dairy products cut type 2 diabetes risk

Incidence of type 2 diabetes was lower in patients who reported higher intakes of high-fat dairy compared with patients who reported lower intake.